HLA-G and neoplasm: The expression of HLA-G in liver tumors or the high-level expression of sHLA-G in HCC patients can free tumor cells from the immune response and inhibit the properties of immune cells such as T8 lymphocytes, NK cells, B cells, and dendritic cells.